Long-term results of Nivolumab + Cabozantinib in RCC

Published Date: 08 Mar 2023

The combination of first-line nivolumab and cabozantinib continues to outperform sunitinib in the treatment of patients with advanced renal cell carcinoma (RCC).

Read Full News

Latest News



Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Fake Cancer Drugs; Let's Talk About Sex; Reducing Cancer-Related Fatigue

2.

Common intracellular toxin could help fight leukemia

3.

Research finds COVID-19 mRNA vaccine sparks immune response to fight cancer

4.

Potential targets for treating the most common type of liver cancer in children have been identified by a collaborative study.

5.

Hospital receives 300 backpacks designed to help kids get leukemia treatment on the go


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot